INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

82,081 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
Page 1637 of 2053
← PrevNext →
traded Jan 30, 2026
+0d
SEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$365K
3,071 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
MM
McCabe Matthew M.EVP & CMO
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
499 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
LP
Lawrence Steven PaulDirector, CEO
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
1,991 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
VL
Vorakoun LisaSVP & CHIEF ACCOUNTING OFFICER
CTOCTO Realty Growth, Inc.
Tax withholding
F$33K
1,876 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
64.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
CA
Caldwell Christopher ADirector, President and CEO
CNXCConcentrix Corp
Grant or award
A—
2,855 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
114.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
PA
Porter Tracy AEVP and General Counsel
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
36.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Grant or award
A$48K
4,000 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
AA
Alonso Lisa AEVP and Chief HR Officer
DOCHEALTHPEAK PROPERTIES, INC.
Tax withholding
F$4,463
252 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Grant or award
A—
71.6K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
AA
Alonso Lisa AEVP and Chief HR Officer
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
456 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Derivative conversion
C—
6.15M sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
126.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
HC
Hicks Ken CDirector
ASOAcademy Sports & Outdoors, Inc.
Tax withholding
F$22K
402 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
110.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
HS
Hammock SamanthaEVP & Chief HR Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$989
87 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
LP
Lawrence Steven PaulDirector, CEO
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
1,991 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
105.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
RK
Ratzan Brian K.Director
SMPLSimply Good Foods Co
Grant or award
A—
6,500 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
HC
Holmes Rob CChairman, President and CEO
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
9,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
WA
Wolpert Geoffrey AlanDirector
SMBKSMARTFINANCIAL INC.
Grant or award
A—
808 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
FC
Ford Earl Carlton IVEVP & CFO
ASOAcademy Sports & Outdoors, Inc.
Tax withholding
F$12K
223 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
BR
Bohn Scott RCDO and Head of Lab
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
28.2K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
237.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
PA
Porter Tracy AEVP and General Counsel
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
11.3K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
355.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
291.5K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
BR
Bohn Scott RCDO and Head of Lab
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
2,396 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
VS
Valentine Andre SChief Financial Officer
CNXCConcentrix Corp
Tax withholding
F$4,722
130 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
74.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,887 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
291.5K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
MG
Mabry Adam GCIO
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
31.6K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
SL
Stillwell Mary-LeeSVP and Controller
VZVERIZON COMMUNICATIONS INC
Grant or award
A$585
51 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
291.5K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
LP
Lawrence Steven PaulDirector, CEO
ASOAcademy Sports & Outdoors, Inc.
Tax withholding
F$46K
839 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence